Contract Packaging Organisations (CPOs) are no longer seen as secondary players handling the final stage of drug delivery. This in-depth article by PharmaSource showcases how CPOs are evolving into strategic partners at the core of pharmaceutical innovation and supply chain efficiency.

With contribution from Tjoapack CEO, Dexter Tjoa, the article outlines the key drivers behind this transformation:

• Demand for Customization: The rise of personalized medicine and complex therapies requires flexible, scalable packaging solutions.
• Compliance and Risk Management: Increasing regulatory scrutiny puts pressure on pharma companies to work with CPOs who can guarantee robust, traceable     processes.
• Technology and Digital Integration: CPOs are investing in serialization, automation, and data analytics to deliver transparency and real-time supply chain insights.
• Post-Pandemic Supply Agility: Lessons from COVID-19 have elevated the need for geographically diversified, responsive packaging networks.
  ‍

Ultimately, CPOs are becoming not just service providers, but value creators—helping pharmaceutical companies bring therapies to patients faster, safer, and more efficiently.

📖 Read the full article

‍

‍